Curaleaf Holdings, Inc. Stock (CURLF) - Quote OTC Markets- MarketScreener (2024)

CURALEAF HOLDINGS, INC.

Add to a list

To use this feature you must be a member

Log inSign up

Equities

CURLF

CA23126M1023

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 03:58:30 2024-06-12 pm EDT			5-day change	1st Jan Change
4.46 ^USD	+2.16%		-1.11%	+9.85%

Jun. 10	KindlyMD Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah	CI
May. 24	Curaleaf "Disagrees" With Miller Amendment to 2018 Farm Bill in U.S.	MT

Financials (USD)

Sales 2024 *	1.41B	Sales 2025 *	1.54B	Capitalization	3.32B
Net income 2024 *	-149M	Net income 2025 *	-57M	EV / Sales 2024 *	2.74x
Net Debt 2024 *	538M	Net Debt 2025 *	728M	EV / Sales 2025 *	2.62x
P/E ratio 2024 *	-25x	P/E ratio 2025 *	-46.2x	Employees	5,650
Yield 2024 *	-	Yield 2025 *	-	Free-Float	61.1%

More Fundamentals * Assessed data

Chart Curaleaf Holdings, Inc.

Duration

Latest news about Curaleaf Holdings, Inc.

KindlyMD Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah	Jun. 10	CI
Curaleaf "Disagrees" With Miller Amendment to 2018 Farm Bill in U.S.	May. 24	MT
Curaleaf Holdings, Inc. Celebrates Miami North Biscayne Dispensary Opening	May. 22	CI
Cannabis stocks rally after DOJ proposal to reclassify marijuana	May. 16	RE
US Government Reclassifies Marijuana to Less-Restrictive Category	May. 16	MT
Justice Department Set to Post Cannabis Reclassification Plans	May. 16	MT
Needham Adjusts Price Target on Curaleaf to $6.25 From $5.25, Keeps Buy Rating	May. 10	MT
Curaleaf Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Transcript : Curaleaf Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
Curaleaf Brief: Q1 Revenue of US$339 Million	May. 09	MT
Investors wary of US cannabis ETFs despite recent rally	May. 07	RE
INSTANT VIEW-Biden administration plans to reclassify marijuana	Apr. 30	RE
DEA to Move to Reclassify Marijuana, Associated Press Reports	Apr. 30	MT
Curaleaf Brief: Completed Acquisition of Northern Green Canada	Apr. 22	MT
Curaleaf Holdings, Inc. completed the acquisition of Northern Green Canada Inc. for approximately $16 million.	Apr. 21	CI

More news

Latest transcript on Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024

May. 09

More transcripts

Analyst Recommendations on Curaleaf Holdings, Inc.

Needham Adjusts Price Target on Curaleaf to $6.25 From $5.25, Keeps Buy Rating	May. 10	MT
Investors wary of US cannabis ETFs despite recent rally	May. 07	RE
Cannabis Stocks Retreat After WSJ Report of DEA Concerns	Mar. 11	DJ

More recommendations

Press releases Curaleaf Holdings, Inc.

Curaleaf Expands Product Portfolio with Launch of Select Fruit Stiq	May. 29	PR
Curaleaf Expands Product Portfolio with Launch of Select Fruit Stiq	May. 29	AQ
Curaleaf Responds to Miller Amendment to NDAA / Farm Bill	May. 24	PR
Curaleaf Responds to Miller Amendment to NDAA / Farm Bill	May. 24	AQ
Curaleaf Celebrates Miami North Biscayne Dispensary Opening	May. 22	PR

More press releases

News in other languages on Curaleaf Holdings, Inc.

Acciones de firmas relacionadas a la marihuana escalan tras conocerse que DEA de EEUU reclasificaría el cannabis	Apr. 30
Curaleaf International kommentiert die schnelle Verabschiedung des deutschen Bundes-Cannabisgesetzes	Mar. 22

More news

Quotes and Performance

1 day	+2.16%
1 week	-1.11%
Current month	-3.88%
1 month	-18.91%
3 months	+15.84%
6 months	+7.99%
Current year	+9.85%

More quotes

Highs and lows

1 week

4.25

4.51

1 month

4.25

6.01

Current year

3.79

6.40

1 year

2.51

6.40

3 years

2.19

15.02

5 years

2.19

18.38

10 years

2.19

18.38

More quotes

Quotes

Date	Price	Change	Volume
24-06-12	4.46	+2.16%	161,490
24-06-11	4.366	-1.23%	226,562
24-06-10	4.42	-1.56%	261,592
24-06-07	4.49	+0.34%	391,332
24-06-06	4.475	-0.11%	232,511

Delayed Quote OTC Markets, June 12, 2024 at 03:58 pm EDT

More quotes

Company Profile

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.

Sector

Pharmaceuticals

Calendar

2024-06-14 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Curaleaf Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.365USD

Average target price

8.507USD

Spread / Average Target

+94.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Recreational Pharmaceuticals

	1st Jan change	Capi.
TRULIEVE CANNABIS CORP.	+91.68%	1.8B
GOODNESS GROWTH HOLDINGS, INC.	+141.27%	84.41M

Recreational Pharmaceuticals

Stock Market
Equities
CURA Stock
CURLF Stock

Secure and Increase the Performance of your Investments with our Team of Experts at your Side Securing my Investments

"); InvestingChannelQueue.push(function() { aICTags["oop"] = ic_page.defineOutOfPageTag("4Traders/quotepages","zppOOP"); aICTags["oop"].setKval({"adslot":"d_OOP_1"}); aICTags["oop"].render(); }); while (aAdsQueue.length) { (aAdsQueue.shift())(); } InvestingChannelQueue.push(function() { displayViewableAds('InvestingChannel'); $( window ).scroll(function() { displayViewableAds('InvestingChannel'); }); }); }gaEvent('adspv', 'InvestingChannel', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '120797236');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });